We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A report from the White House Council of Economic Advisors on measuring prescription drug prices finds that the CPI Prescription Drug Index (CPI-Rx) prepared by the Bureau of Labor Statistics is “the best available summary measure” of the prescription drug price changes — but some groups claim it’s flawed because it leaves out new, expensive drugs. Read More
In an usual move, the Institute for Clinical and Economic Review (ICER) quickly withdrew a draft report that questioned the cost-effectiveness of three rheumatoid arthritis treatments, saying that it needs to reconsider its approach. Read More
President Trump hinted that a drug importation proposal is coming soon from HHS, during a Thursday speech on an executive order aimed at improving Medicare. Read More
The expanded recall included an additional three lots of losartan potassium tablets and two lots of losartan potassium/hydrocholorothiazide tablets. Read More
The FDA warned manufacturers of ranitidine products not to use a high-temperature test for N-Nitrosodimethylamine (NDMA) because it actually generates high levels of the impurity. Read More